Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management

N. Brodszki, A. Frazer-Abel, AS. Grumach, M. Kirschfink, J. Litzman, E. Perez, MRJ. Seppänen, KE. Sullivan, S. Jolles

. 2020 ; 40 (4) : 576-591. [pub] 20200217

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026715

This guideline aims to describe the complement system and the functions of the constituent pathways, with particular focus on primary immunodeficiencies (PIDs) and their diagnosis and management. The complement system is a crucial part of the innate immune system, with multiple membrane-bound and soluble components. There are three distinct enzymatic cascade pathways within the complement system, the classical, alternative and lectin pathways, which converge with the cleavage of central C3. Complement deficiencies account for ~5% of PIDs. The clinical consequences of inherited defects in the complement system are protean and include increased susceptibility to infection, autoimmune diseases (e.g., systemic lupus erythematosus), age-related macular degeneration, renal disorders (e.g., atypical hemolytic uremic syndrome) and angioedema. Modern complement analysis allows an in-depth insight into the functional and molecular basis of nearly all complement deficiencies. However, therapeutic options remain relatively limited for the majority of complement deficiencies with the exception of hereditary angioedema and inhibition of an overactivated complement system in regulation defects. Current management strategies for complement disorders associated with infection include education, family testing, vaccinations, antibiotics and emergency planning.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026715
003      
CZ-PrNML
005      
20211026132658.0
007      
ta
008      
211013s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10875-020-00754-1 $2 doi
035    __
$a (PubMed)32064578
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Brodszki, Nicholas $u Department of Pediatrics, Children's Hospital, Skåne University Hospital, Lund, Sweden
245    10
$a European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management / $c N. Brodszki, A. Frazer-Abel, AS. Grumach, M. Kirschfink, J. Litzman, E. Perez, MRJ. Seppänen, KE. Sullivan, S. Jolles
520    9_
$a This guideline aims to describe the complement system and the functions of the constituent pathways, with particular focus on primary immunodeficiencies (PIDs) and their diagnosis and management. The complement system is a crucial part of the innate immune system, with multiple membrane-bound and soluble components. There are three distinct enzymatic cascade pathways within the complement system, the classical, alternative and lectin pathways, which converge with the cleavage of central C3. Complement deficiencies account for ~5% of PIDs. The clinical consequences of inherited defects in the complement system are protean and include increased susceptibility to infection, autoimmune diseases (e.g., systemic lupus erythematosus), age-related macular degeneration, renal disorders (e.g., atypical hemolytic uremic syndrome) and angioedema. Modern complement analysis allows an in-depth insight into the functional and molecular basis of nearly all complement deficiencies. However, therapeutic options remain relatively limited for the majority of complement deficiencies with the exception of hereditary angioedema and inhibition of an overactivated complement system in regulation defects. Current management strategies for complement disorders associated with infection include education, family testing, vaccinations, antibiotics and emergency planning.
650    _2
$a autoimunitní nemoci $x diagnóza $x genetika $x terapie $7 D001327
650    _2
$a komplement $x genetika $7 D003165
650    _2
$a náchylnost k nemoci $7 D004198
650    _2
$a genetické testování $7 D005820
650    _2
$a lidé $7 D006801
650    _2
$a infekce $7 D007239
650    _2
$a zánět $x diagnóza $x genetika $x terapie $7 D007249
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a vzdělávání pacientů jako téma $7 D010353
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a primární imunodeficience $x diagnóza $x genetika $x terapie $7 D000081207
650    _2
$a společnosti lékařské $7 D012955
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Frazer-Abel, Ashley $u Division of Rheumatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA
700    1_
$a Grumach, Anete S $u Clinical Immunology, Reference Center on Rare Diseases, University Center Health ABC, Santo Andre, SP, Brazil
700    1_
$a Kirschfink, Michael $u Institute of Immunology, University of Heidelberg, Heidelberg, Germany
700    1_
$a Litzman, Jiri $u Department of Clinical Immunology and Allergology, St Anne's University Hospital, and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Perez, Elena $u Allergy Associates of the Palm Beaches, North Palm Beach, FL, USA
700    1_
$a Seppänen, Mikko R J $u Rare Disease Center, Children's Hospital, and Adult Primary Immunodeficiency Outpatient Clinic, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
700    1_
$a Sullivan, Kathleen E $u Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
700    1_
$a Jolles, Stephen $u Immunodeficiency Centre for Wales, Cardiff University & University Hospital of Wales, Cardiff, UK. jollessr@cardiff.ac.uk
773    0_
$w MED00002589 $t Journal of clinical immunology $x 1573-2592 $g Roč. 40, č. 4 (2020), s. 576-591
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32064578 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132705 $b ABA008
999    __
$a ok $b bmc $g 1715452 $s 1147222
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 40 $c 4 $d 576-591 $e 20200217 $i 1573-2592 $m Journal of clinical immunology $n J Clin Immunol $x MED00002589
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace